Literature DB >> 21628650

Adjusting for heterogeneity of malaria transmission in longitudinal studies.

Teun Bousema, Benno Kreuels, Roly Gosling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21628650      PMCID： PMC3307167          DOI： 10.1093/infdis/jir225

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  19 in total

1.  Genetic variation in human HBB is associated with Plasmodium falciparum transmission.

Authors:  Louis Clement Gouagna; Germana Bancone; Frank Yao; Bienvenue Yameogo; Kounbobr Roch Dabiré; Carlo Costantini; Jacques Simporé; Jean Bosco Ouedraogo; David Modiano
Journal:  Nat Genet       Date:  2010-03-21       Impact factor: 38.330

2.  Identification of hot spots of malaria transmission for targeted malaria control.

Authors:  Teun Bousema; Chris Drakeley; Samwel Gesase; Ramadhan Hashim; Stephen Magesa; Frank Mosha; Silas Otieno; Ilona Carneiro; Jonathan Cox; Eliapendavyo Msuya; Immo Kleinschmidt; Caroline Maxwell; Brian Greenwood; Eleanor Riley; Robert Sauerwein; Daniel Chandramohan; Roly Gosling
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

3.  Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia.

Authors:  Jonathan J Juliano; Frederic Ariey; Rithy Sem; Noppadon Tangpukdee; Srivicha Krudsood; Carol Olson; Sornchai Looareesuwan; William O Rogers; Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

4.  Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008.

Authors:  Teun Bousema; Randa M Youssef; Jackie Cook; Jonathan Cox; Victor A Alegana; Jamal Amran; Abdisalan M Noor; Robert W Snow; Chris Drakeley
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

5.  Placental malaria increases malaria risk in the first 30 months of life.

Authors:  Norbert G Schwarz; Ayola A Adegnika; Lutz P Breitling; Julian Gabor; Selidji T Agnandji; Robert D Newman; Bertrand Lell; Saadou Issifou; Maria Yazdanbakhsh; Adrian J F Luty; Peter G Kremsner; Martin P Grobusch
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

Review 6.  Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis.

Authors:  Lucy C Okell; Azra C Ghani; Emily Lyons; Chris J Drakeley
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

7.  Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.

Authors:  Tamara D Clark; Bryan Greenhouse; Denise Njama-Meya; Bridget Nzarubara; Catherine Maiteki-Sebuguzi; Sarah G Staedke; Edmund Seto; Moses R Kamya; Philip J Rosenthal; Grant Dorsey
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

8.  Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.

Authors:  Philip Bejon; George Warimwe; Claire L Mackintosh; Margaret J Mackinnon; Sam M Kinyanjui; Jennifer N Musyoki; Peter C Bull; Kevin Marsh
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

9.  Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity.

Authors:  Benno Kreuels; Robin Kobbe; Samuel Adjei; Christina Kreuzberg; Claudia von Reden; Kathrin Bäter; Stefan Klug; Wibke Busch; Ohene Adjei; Jürgen May
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

10.  Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children.

Authors:  Sylvia Males; Oumar Gaye; André Garcia
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079
View more
  14 in total

1.  Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Authors:  Danielle I Stanisic; Freya J I Fowkes; Melanie Koinari; Sarah Javati; Enmoore Lin; Benson Kiniboro; Jack S Richards; Leanne J Robinson; Louis Schofield; James W Kazura; Christopher L King; Peter Zimmerman; Ingrid Felger; Peter M Siba; Ivo Mueller; James G Beeson
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

2.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.

Authors:  Danica A Helb; Kevin K A Tetteh; Philip L Felgner; Jeff Skinner; Alan Hubbard; Emmanuel Arinaitwe; Harriet Mayanja-Kizza; Isaac Ssewanyana; Moses R Kamya; James G Beeson; Jordan Tappero; David L Smith; Peter D Crompton; Philip J Rosenthal; Grant Dorsey; Christopher J Drakeley; Bryan Greenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

3.  Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.

Authors:  Tuan M Tran; Aissata Ongoiba; Jill Coursen; Cecile Crosnier; Ababacar Diouf; Chiung-Yu Huang; Shanping Li; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Aboudramane Bathily; Seydou Dia; Moussa Niangaly; Charles Dara; Jules Sangala; Louis H Miller; Ogobara K Doumbo; Kassoum Kayentao; Carole A Long; Kazutoyo Miura; Gavin J Wright; Boubacar Traore; Peter D Crompton
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

4.  IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.

Authors:  Will Stone; Teun Bousema; Sophie Jones; Samwel Gesase; Rhamadhan Hashim; Roly Gosling; Ilona Carneiro; Daniel Chandramohan; Thor Theander; Raffaele Ronca; David Modiano; Bruno Arcà; Chris Drakeley
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.

Authors:  Kingsley Badu; Ben Gyan; Maxwell Appawu; Daniel Mensah; Daniel Dodoo; Guiyun Yan; Chris Drakeley; Guofa Zhou; Ellis Owusu-Dabo; Kwadwo Ansah Koram
Journal:  Parasit Vectors       Date:  2015-04-28       Impact factor: 3.876

6.  Time-to-infection by Plasmodium falciparum is largely determined by random factors.

Authors:  Mykola Pinkevych; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport
Journal:  BMC Med       Date:  2015-01-30       Impact factor: 8.775

7.  Spatially variable risk factors for malaria in a geographically heterogeneous landscape, western Kenya: an explorative study.

Authors:  Tobias Homan; Nicolas Maire; Alexandra Hiscox; Aurelio Di Pasquale; Ibrahim Kiche; Kelvin Onoka; Collins Mweresa; Wolfgang R Mukabana; Amanda Ross; Thomas A Smith; Willem Takken
Journal:  Malar J       Date:  2016-01-04       Impact factor: 2.979

8.  The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial.

Authors:  Teun Bousema; Jennifer Stevenson; Amrish Baidjoe; Gillian Stresman; Jamie T Griffin; Immo Kleinschmidt; Edmond J Remarque; John Vulule; Nabie Bayoh; Kayla Laserson; Meghna Desai; Robert Sauerwein; Chris Drakeley; Jonathan Cox
Journal:  Trials       Date:  2013-02-02       Impact factor: 2.279

9.  A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.

Authors:  Alfred B Tiono; Alphonse Ouédraogo; Bernhards Ogutu; Amidou Diarra; Sam Coulibaly; Adama Gansané; Sodiomon B Sirima; Gregory O'Neil; Amitava Mukhopadhyay; Kamal Hamed
Journal:  Malar J       Date:  2013-02-27       Impact factor: 2.979

10.  Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.

Authors:  Katherine E Halliday; George Okello; Elizabeth L Turner; Kiambo Njagi; Carlos Mcharo; Juddy Kengo; Elizabeth Allen; Margaret M Dubeck; Matthew C H Jukes; Simon J Brooker
Journal:  PLoS Med       Date:  2014-01-28       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.